Luther King Capital Management (LKCM)’s ResMed RMD Stock Holding History

Luther King Capital Management (LKCM)’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,124	Closed	-$252K	–	602
2025 Q1	$252K	Buy	+1,124	New	+$262K	﹤0.01%	543

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Luther King Capital Management (LKCM)'s RMD Position: Q2 2025 in Review

Luther King Capital Management (LKCM) sold out of ResMed (RMD) in Q2 2025, closing a stake of 1,124 shares — an estimated $252K sold.

Luther King Capital Management (LKCM) first reported a position in RMD in Q1 2025 and held it in 1 quarter. The position peaked at $252K in Q1 2025. 919 funds tracked by Wall St. Rank hold RMD as of Q2 2025.

Luther King Capital Management (LKCM) reported no remaining ResMed position as of Q2 2025 after selling out during the quarter.
Luther King Capital Management (LKCM) sold 1,124 ResMed shares in Q2 2025, an estimated $252K.
Luther King Capital Management (LKCM) first reported a position in ResMed in Q1 2025 and held it in 1 quarter.
Luther King Capital Management (LKCM)'s ResMed position peaked at $252K in Q1 2025.
919 funds tracked by Wall St. Rank held ResMed as of Q2 2025.

Based on Luther King Capital Management (LKCM)'s 13F filing for Q2 2025, filed 7 Aug 2025.